1. Home
  2. CSTL vs KODK Comparison

CSTL vs KODK Comparison

Compare CSTL & KODK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSTL
  • KODK
  • Stock Information
  • Founded
  • CSTL 2007
  • KODK 1880
  • Country
  • CSTL United States
  • KODK United States
  • Employees
  • CSTL N/A
  • KODK N/A
  • Industry
  • CSTL Medical Specialities
  • KODK Business Services
  • Sector
  • CSTL Health Care
  • KODK Consumer Discretionary
  • Exchange
  • CSTL Nasdaq
  • KODK Nasdaq
  • Market Cap
  • CSTL 456.2M
  • KODK 469.3M
  • IPO Year
  • CSTL 2019
  • KODK N/A
  • Fundamental
  • Price
  • CSTL $20.49
  • KODK $5.82
  • Analyst Decision
  • CSTL Strong Buy
  • KODK
  • Analyst Count
  • CSTL 6
  • KODK 0
  • Target Price
  • CSTL $37.67
  • KODK N/A
  • AVG Volume (30 Days)
  • CSTL 449.7K
  • KODK 833.6K
  • Earning Date
  • CSTL 08-04-2025
  • KODK 08-07-2025
  • Dividend Yield
  • CSTL N/A
  • KODK N/A
  • EPS Growth
  • CSTL N/A
  • KODK N/A
  • EPS
  • CSTL N/A
  • KODK 0.52
  • Revenue
  • CSTL $347,083,000.00
  • KODK $1,041,000,000.00
  • Revenue This Year
  • CSTL N/A
  • KODK N/A
  • Revenue Next Year
  • CSTL $1.36
  • KODK N/A
  • P/E Ratio
  • CSTL N/A
  • KODK $11.12
  • Revenue Growth
  • CSTL 38.43
  • KODK N/A
  • 52 Week Low
  • CSTL $15.45
  • KODK $4.26
  • 52 Week High
  • CSTL $35.84
  • KODK $8.24
  • Technical
  • Relative Strength Index (RSI)
  • CSTL 67.41
  • KODK 44.05
  • Support Level
  • CSTL $18.18
  • KODK $5.62
  • Resistance Level
  • CSTL $20.63
  • KODK $5.84
  • Average True Range (ATR)
  • CSTL 0.78
  • KODK 0.18
  • MACD
  • CSTL 0.22
  • KODK 0.01
  • Stochastic Oscillator
  • CSTL 85.79
  • KODK 15.49

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.

About KODK Eastman Kodak Company Common New

Eastman Kodak Co is a United States-based company. It operates through several business segments; Print, Brand, and Advanced Materials and Chemicals. The Print segment which derives the majority of revenue includes products like digital offset plate offerings and computer-to-plate imaging solutions, high-quality digital printing solutions using electrically charged toner-based technology, production press systems, consumables, inkjet components, software and services. Geographically, the company generates revenue from the United States, Canada, Europe, Middle East and Africa, Asia Pacific, and Latin America.

Share on Social Networks: